Shanghai Fosun Pharmaceutical (02196): Application for registration of oxazepam tablets received approval from the National Medical Products Administration

Shanghai Fosun Pharmaceutical (02196) announced that the application for the listing registration of oxazepam tablets (hereinafter referred to as "the drug") of its controlling subsidiary, Hunan Dongting Pharmaceutical Co., Ltd., was recently approved by the National Medical Products Administration.